Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial

Fig. 1

The effect of metformin on resting blood pressure and drop in blood pressure from resting in a supine position to standing. Estimates are adjusted for baseline values of outcomes, changes during trial in vitamin B12, methylmalonic acid ang HbA1c and in addition pre-trial treatment of metformin. Effects are shown as mmHg and 95% CI. *p = 0.02. **p = 0.045 Only estimates for Model 3 are illustrated

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840